Health Care: Drugs

Infinity Pharmaceuticals Inc (INFI: NASDAQ)

$1.2 n/a | n/a%
12/02/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.20
52 Week High 8.19
52 Week Low 0.84
Avg. Daily Vol. (Mil) 0.49
Beta (3 year) 2.21
Share Related Items
Mkt Cap (Mil) 59.68
Shares Out (Mil) 49.73
Float (Mil) 33.02
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.30
Current Ratio 3.60
LT Debt/ Equity 0.16
Total Debt / Equity 0.17
Valuation Ratios
Price Earnings 4.40
Price/Sales 0.50
Price/Book 0.50
Price/Cash Flow 3.60
Per Share Data
Earnings 0.27
Sales 2.38
Book Value 2.39
Cash Flow 0.33
Business Summary
Infinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its product candidate is duvelisib, also known as IPI-145, an oral inhibitor.
General Information
784 Memorial Drive
Cambridge, MA 02139
Industry : Drugs
Sector: Health Care
Employees: 164
CEO: Ms. Adelene Q. Perkins
Short Interest
Current Month (Mil) 2.18
Previous Month (Mil) 2.16
Short Interest Ratio (Days) 3.70
Management Effectiveness
Return on Equity 13.20
Return on Assets 8.40
Return on Investments 11.30
Gross Margin n.a.
EBIT Margin 12.20
Profit Margin 13.20

Portfolios with INFI

Latest INFI Headlines from TheStreet

More Financial News for INFI

Press Releases for INFI

See All Press Releases

Partner Headlines for INFI

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter